SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, multiple severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increasing ability to …
Innate metabolic responses against viral infections
CS Palmer - Nature Metabolism, 2022 - nature.com
Metabolic adaptation to viral infections critically determines the course and manifestations of
disease. At the systemic level, a significant feature of viral infection and inflammation that …
disease. At the systemic level, a significant feature of viral infection and inflammation that …
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery
The host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection can result in prolonged pathologies collectively referred to as post-acute sequalae …
infection can result in prolonged pathologies collectively referred to as post-acute sequalae …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
EA Barreto, AS Cruz, FP Veras… - Proceedings of the …, 2023 - National Acad Sciences
Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in
COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers …
COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers …
Choosing a cellular model to study SARS-CoV-2
GA Pires De Souza, M Le Bideau, C Boschi… - Frontiers in cellular …, 2022 - frontiersin.org
As new pathogens emerge, new challenges must be faced. This is no different in infectious
disease research, where identifying the best tools available in laboratories to conduct an …
disease research, where identifying the best tools available in laboratories to conduct an …
[HTML][HTML] COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
P Li, Y Liu, Z Cheng, X Yu, Y Li - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
Long-term gastrointestinal outcomes of COVID-19
A comprehensive evaluation of the risks and 1-year burdens of gastrointestinal disorders in
the post-acute phase of COVID-19 is needed but is not yet available. Here we use the US …
the post-acute phase of COVID-19 is needed but is not yet available. Here we use the US …
Diabetes mellitus, energy metabolism, and COVID-19
C Conte, E Cipponeri, M Roden - Endocrine Reviews, 2024 - academic.oup.com
Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …